MedTrace Logo

Effects of Altitude on Single-Breath Diffusing Capacity for Carbon Monoxide

NCT03235297 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2020-02-12

No results posted yet for this study

Summary

The purpose of this study is to further understand the effects of altitude on the physiology of gas exchange in the pulmonary microcirculation in normal subjects and in people with chronic obstructive pulmonary disease (COPD) measured as the single-breath diffusing capacity for carbon monoxide (DLCOsb). The study will determine a mathematical formula to allow for altitude corrections in both study populations to be used clinically in pulmonary labs.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Matt Hegewald, MD · Intermountain Health Care, Inc.

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-10
Primary Completion
2018-06-15
Completion
2019-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03235297 on ClinicalTrials.gov